Movement, Abnormal, Pain, Postural; Defect, Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
The aim of this study is to investigate body awareness and functional movement in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to healthy controls.
Detailed description
It is aimed at investigating body awareness, and functional movement, and related factors in patients with COPD. The secondary purpose is to determine correlations between body awareness and functional movement, respiratory muscle strength and endurance, daily living activities, posture, and pain threshold in this study. The determination of correlations between functional movement, respiratory pattern, and functional exercise capacity is also purposed. In accordance with these purposes, at least 30 patients with COPD will be included and at least 30 healthy controls will be included. Tests and questionnaires will be used in order to determine the severity of disease. Lung function test and respiratory muscle strength and endurance test will be performed. Six Minute Walk Test will be performed for functional exercise capacity. To evaluate posture, the Corbin Postural Assessment Scale will be used. Pain and pain threshold will be assessed via Visual Analog Scale and an algometer, respectively. Body Awareness Rating Questionnaire will be used for evaluating body awareness. To evaluate daily living activities, Glittre Activities of Daily Living Test will be used. The Functional Movement Screen Test will be used for functional movement analysis. According to the results to be obtained, body awareness and functional movement will be determined in patients with COPD. It will guide professional working in this field.
Interventions
None listed
Sponsors
Hacettepe University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
for Chronic Obstructive Pulmonary Disease Group * Being under 55 years old * To be literate, * Having volunteered to participate in the research, * Stage 1-2-3-4 according to the Classification of Airflow Limitation in COPD (GOLD) system, * Being clinically stable for the last 2 weeks.
Exclusion criteria
for Chronic Obstructive Pulmonary Disease Group * Having history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery, * Communication problems, * Having a severe psychiatric disorder. Inclusion Criteria for Healthy Control Group * Not having any cardiopulmonary system disease or chronic systemic disease, * To be literate, * Being under 55 years old * Be willing to participate in the study. * Not having balance problems, musculoskeletal, neurological and psychiatric disorders that could prevent performing the test procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of functional movement | 1 day | Functional movement analysis will be performed via The Functional Movement Screen. |
| Evaluation of Body Awareness | 1 day | Body awareness will be assessed via Body Awareness Rating Questionnaire. It consists of 24 questions and each item is scored on a 7-point Likert-type scale. The total score ranges from 24 to168. A Higher scores indicate higher body awareness. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Posture | 1 day | Posture will be examined via the Corbin Postural Assessment Scale. The total points of the Corbin Postural Assessment Scale range from 0 to 28 points. A higher point represents worse posture. |
| Daily living activities | 1 day | Daily living activities will be evaluated via Glittre Activities of Daily Living Test. |
| Severity of disease | 1 day | Global Initiative for Chronic Obstructive Pulmonary Disease and Global Initiative for Chronic Obstructive Pulmonary ABE assessment Tool will be used for severity of disease. According to the Global Initiative for Chronic Obstructive Pulmonary Disease, the severity of airflow limitation (Forced Expiratory Volume in 1 s) was determined as mild (≥ 80%), moderate (50-80%), severe (30-50%), and very severe (\<30%). According to Global Initiative for Chronic Obstructive Pulmonary A,B,E assessment Tool, patients classified group A, B, and E using symptom status and airflow limitation. |
| Functional exercise capacity | 1 day | Functional exercise capacity will be assessed via Six minute walk test. |
| Pain Severity | 1 day | Severity of pain will be assessed via Visual Analog Scale. Zero point is defined as no pain and ten point as unbearable pain. Total point ranges from 0 to 10. |
| Respiratory muscle endurance | 1 day | Respiratory muscle endurance will be assessed using the maximal incremental loading technique and constant loading technique using a device according to the European Respiratory Society guidelines. |
| Dyspnea | 1 day | The Modified Medical Research Council will be used for patients with COPD. The Modified Medical Research Council consist of five grades. A higher grades represents severe dyspnea level. |
| Symptoms | 1 day | Chronic Obstructive Pulmonary Disease Assessment Test will be used to determine symptoms. The total score of Chronic Obstructive Pulmonary Disease Assessment Test changes from 0 to 40 points, and 10 points is the accepted cut-off point for COPD. |
| Respiratory muscle strength | 1 | Respiratory muscle strength will be assessed via a using a mouth pressure device according to American Thoracic Society/ European Respiratory Society guidelines. |
| Pain threshold | 1 day | Pain threshold will be assessed via an algometer. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactAynur Demirel, PhD
Backup ContactHidaye Yamikan, PT,MSc
Outcome results
None listed